Last quarter (Q3 2023), Vir Biotechnology's total revenue was $2.64M, a decrease of -99.29% from the same quarter last year. In Q3, Vir Biotechnology's net income was $-163.41M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 40.61M	$ 1.62B	-	$ 67.25M	$ 8.09M	$ 10.67M
Cost of Revenue	$ -4.05M	$ 146.32M	$ -65.86M	$ 0.00	-	-
Gross Profit	$ 67.00M	$ 1.47B	$ 1.02B	$ 67.25M	-	-
Operating Expense	$ 806.65M	$ 636.41M	$ 608.80M	$ 364.23M	$ 186.07M	$ 129.36M
Operating Income	$ -739.66M	$ 833.07M	$ 412.40M	$ -296.98M	$ -177.98M	$ -118.69M
Net Non Operating Interest Income Expense	-	-	-	$ 2.84M	$ 8.51M	$ 2.54M
Other Income Expense	$ -80.58M	$ 43.46M	$ -137.40M	$ -4.47M	$ -5.06M	$ -212.00K
Pretax Income	$ -659.08M	$ 754.28M	$ 549.80M	$ -298.61M	$ -174.53M	$ -116.36M
Tax Provision	$ -58.33M	$ 238.44M	$ 21.22M	$ 54.00K	$ 154.00K	$ -480.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -600.69M	$ 515.84M	$ 528.58M	$ -298.67M	$ -174.68M	$ -115.88M
Basic EPS	$ -4.51	$ 3.89	$ 4.07	$ -2.51	$ -5.76	$ -1.20
Diluted EPS	$ -4.47	$ 3.83	$ 3.96	$ -2.51	$ -5.76	$ -1.20
Basic Average Shares	$ 534.51M	$ 132.61M	$ 129.88M	$ 119.16M	$ 30.35M	$ 96.91M
Diluted Average Shares	$ 536.71M	$ 134.81M	$ 133.44M	$ 119.16M	$ 30.35M	$ 96.91M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 802.60M	$ 782.73M	$ 542.93M	$ 364.23M	$ 186.07M	$ 129.36M
Net Income From Continuing And Discontinued Operation	$ -600.75M	$ 515.84M	$ 528.58M	$ -298.67M	$ -174.68M	$ -115.88M
Normalized Income	$ -370.31M	$ 595.88M	-	$ -298.67M	$ -174.68M	$ -115.88M
Interest Expense	-	-	-	-	-	-
EBIT	$ -659.04M	$ 754.28M	$ 549.80M	$ -296.98M	$ -177.98M	$ -118.69M
EBITDA	$ -500.12M	$ 752.12M	$ 555.37M	$ -291.54M	$ -173.46M	$ -115.94M

Currency in USD

Vir Biotechnology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing